IMVARIA is advancing noninvasive AI biomarkers for better patient lives. We bring artificial intelligence to imaging and lab data, re-imagining clinical assessments in serious diseases.
IMVARIA serves Fibresolve -- the first AI diagnostic tool in interstitial lung disease (ILD) and idiopathic pulmonary fibrosis (IPF). Fibresolve is an FDA Breakthrough Device and is authorized by the FDA to serve as an adjunctive, non-invasive diagnostic tool for patients with suspected ILD and IPF.
Beyond ILD and IPF, IMVARIA is developing AI biomarkers in multiple areas including oncology, pulmonology, immunology, and more.
Company Details
- Employees
- 7
- Founded
- -
- Address
- Berkeley, Ca 94705, Us
- Phone
- (650) 683-9800
- in****@****ria.com
- Industry
- Medical And Diagnostic Laboratories
- NAICS
-
Medical and Diagnostic LaboratoriesMedical LaboratoriesDiagnostic Imaging Centers
- Website
- imvaria.com
- Keywords
- machine learning, medicine, data science, pulmonary, biopharma, clinical research, renal, hepatic, artificial intelligence, digital biomarkers, IPF, ILD, lung fibrosis, Fibresolve.
- HQ
- Berkeley, CA
Imvaria Questions
Imvaria's helpline number is (650) 683-9800
Imvaria's website is imvaria.com
Imvaria's LinkedIn profile is https://www.linkedin.com/company/imvaria
Imvaria has
7 employees.
View email and phone details for 7
employees at Imvaria.
Imvaria's industry is
Medical and Diagnostic Laboratories
Imvaria's top competitors are
Oxipit,
Smart Reporting Gmbh,
Subtle Medical,
Lucida Medical,
Deepecho,
Ai Medical Ag,
Deephealth,
B-Rayz,
Mediaire,
Milvue.
Imvaria's support email address is info@imvaria.com
Imvaria's categories are Medical and Diagnostic Laboratories
Imvaria's founding year is 2019
